FLU clinical study illustration

Combining the COVID and Flu shot…

– would simplify annual vaccinations
– could prevent infection or severe illness from these diseases

This study is examining combination mRNA COVID and Flu vaccine and investigating whether it offers protection against COVID and Influenza infections.

If you are between 18 and 64 years old, you could qualify for this research study.

COVID Vaccine?

dialogue icon

World-class
Medical Oversight

  • 24-hour access to MBR’s doctors/medical staff.
  • World class medical oversight.
  • Free of Charge!
like icon

Free of Charge!

  • Insurance is NOT required to participate.
  • Free services include:
    – Study related medication
    – Doctor’s visits
    – Physical exams
    – Testing
coins icon
RECEIVE UP TO A $935 STIPEND
  • Those who qualify and choose to participate may receive up to a $935 stipend.
Monroe Biomedical Research - Hero
“mAB treatments were exceedingly effective at treating a COVID-19 infection. Let’s see if this same technology can prevent an influenza infection.

01

Learn More
Register Today

The first step is to learn more and see if you qualify. After registering, a clinical research coordinator will contact you and answer your questions

Sign up using the link below
Call or text +1 704 283 7359

02

Visit Our Center
See If You Qualify

Our facility is state of the art.

Visit our center for a prescreening visit to see if you qualify.

Testimonials

What our Patients say about our services

Research facility

Monroe Biomedical

6300

Square feet Dedicated Research Facility

Cozy

Recreational Area Comfortable Recliners

Fun

Free entertainment options

Friendly

First Class Service from our Nurses and Staff

MBR Staff photo
MBR Staff photo
MBR Staff photo
MBR Staff photo

Free entertainment

Movies and Shows
Personal Tablets
Large Flatscreen TV

High Speed Wifi

Family Friendly

Very Comfortable
Recliners

FLU clinical study illustration

mAB Flu Prevention Study

Influenza is a major cause of illness and death worldwide, with infections becoming widespread on a seasonal basis each year. The risk of complications and hospital admission due to influenza is greatest in people 65 years of age and older, the young, and people with underlying health conditions. Each year in the US more than 200,000 hospital admissions are related to influenza.

The purpose of this study is to evaluate the efficacy, safety, and tolerability of VIR-2482 compared to placebo in preventing influenza A illness in healthy adults 18 to <65 years of age without pre-existing risk factors for serious complications from influenza infection. Click here for more information

Contact Us

Monroe Biomedical Research
343 Venus Street, Monroe, NC 28112

Office Phone: 704-283-7369
Fax: 704-283-7329
Email: patients@monroeresearch.com

FAQ

Frequently Asked Questions

What is Flu disease?
  • Flu disease is a seasonal virus that infects the throat, nose, and sometimes the airways of the lungs. Each year millions of people are suffering from the influenza virus. Healthy adults usually experience mild cold-like symptoms and recover in a few days. In adults aged 65 years and older, individuals with weakened immune systems, and individuals with chronic heart and lung conditions can experience serious infections that can lead to hospitalization and, in some cases, death.
How dangerous is a Flu infection for patients over 65 years old?
  • If you are older than 65 years old you might be at higher risk of developing serious complications compared to younger patients. Flu is an important cause of serious infections and can lead to hospitalization and, in some cases, death. The best way to protect yourself is to get a flu shot every year. 
How much will the study cost?
  • There will be zero costs for the study participant to take part in the Flu shot study.
What if I am uninsured?
  • Proof of insurance is NOT required to participate in this study. All medical oversight over the course of your study participation is included.
What does investigational medication mean?
  • An Investigational medication (also known as investigational new drug) has been approved by the Food and Drug Administration (FDA) for testing in people in a clinical study, but has not been approved for general use, distribution or sale. It is through clinical research that these medications receive full approval by the FDA.
How will I be compensated for participating?
  • Participants receive a check following each study visit. For this study, those that qualify and choose to participate could receive a total payment of up to $935.